Irlanda - inglese - HPRA (Health Products Regulatory Authority)

pharmathen s.a. - atorvastatin - film coated tablet - 40 milligram - hmg coa reductase inhibitors

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

pharmathen s.a. - atorvastatin calcium - film coated tablet - 20 milligram - hmg coa reductase inhibitors

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

pharmathen s.a. - atorvastatin calcium - film coated tablet - 80 milligram - hmg coa reductase inhibitors

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

pharmathen s.a. - atorvastatin calcium - film coated tablet - 10 milligram - hmg coa reductase inhibitors

Australia - inglese - APVMA (Australian Pesticides and Veterinary Medicines Authority)

flotan pty ltd - permethrin (25:75::cis:trans); tetramethrin; liquid hydrocarbon - liquid - permethrin (25:75::cis:trans) pyrethroid active 3.5 g/l; tetramethrin pyrethroid active 1.2 g/l; liquid hydrocarbon solvent other 795.0 g/l - insecticide - commercial/industrial premises | domestic premises | food preparation area | food storage area | indoor domestic area | living a - ant | carpet beetle | cockroach | flea | fly | moth | silverfish | spider | adult | argentine ant | ctenocephalides spp. | ground fleas | large cockroach | pharaoh ant | small cockroach

Stati Uniti - inglese - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 12 years of age and older. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2)] . the limited available data with desloratadine in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats was not teratoge